ALB and Hypoalbuminemia: In the post-treatment hypoalbuminemia group, median PFS (6 months; 95% CI 5–7 months) and median OS (11 months; 95% CI 9–15 months) were significantly shorter than those in the normal post-treatment albumin level group (PFS: 12 months, 95% CI 11–16 months, P < 0.001; OS: 31 months, 95% CI 24–42 months, P < 0.001).